SII to acquire 20% stake in needle-free tech company IntegriMedical
Vaccine manufacturer Serum Institute of India (SII) announced an investment in IntegriMedical, a medical technology company developing needle-free injection systems (N-FIS). This collaboration aims to advance N-FIS technology and make it more accessible to patients globally. SII will acquire a 20 per cent stake in IntegriMedical. This investment is expected to accelerate the development and commercialisation of N-FIS, offering a more comfortable and painless vaccination experience. N-FIS technology uses a high-velocity jet stream to administer medications, eliminating needle phobia and needle-stick injuries. This aligns with SII's mission of "Health for All" and IntegriMedical's goal to "Transform Healthcare Globally." Read more@ https://www.business-standard.com/companies/news/sii-to-acquire-20-stake-in-needle-free-tech-company-integrimedical-124051701190_1.html